Cancer Center, Ordway Research Institute, Albany, NY 12208, USA.
Proc Natl Acad Sci U S A. 2010 Apr 20;107(16):7377-82. doi: 10.1073/pnas.1003055107. Epub 2010 Apr 5.
As a general strategy for function-based gene identification, an shRNA library containing approximately 150 shRNAs per gene was enzymatically generated from normalized (reduced-redundance) human cDNA. The library was constructed in an inducible lentiviral vector, enabling propagation of growth-inhibiting shRNAs and controlled activity measurements. RNAi activities were measured for 101 shRNA clones representing 100 human genes and for 201 shRNAs derived from a firefly luciferase gene. Structure-activity analysis of these two datasets yielded a set of structural criteria for shRNA efficacy, increasing the frequencies of active shRNAs up to 5-fold relative to random sampling. The same library was used to select shRNAs that inhibit breast carcinoma cell growth by targeting potential oncogenes. Genes targeted by the selected shRNAs were enriched for 10 pathways, 9 of which have been previously associated with various cancers, cell cycle progression, or apoptosis. One hundred nineteen genes, enriched through this selection and represented by two to six shRNAs each, were identified as potential cancer drug targets. Short interfering RNAs against 19 of 22 tested genes in this group inhibited cell growth, validating the efficiency of this strategy for high-throughput target gene identification.
作为一种基于功能的基因鉴定的一般策略,从归一化(减少冗余)的人 cDNA 中酶促生成了大约每个基因包含 150 个 shRNA 的 shRNA 文库。该文库构建在诱导性慢病毒载体中,能够增殖生长抑制 shRNA 并进行受控的活性测量。针对代表 100 个人类基因的 101 个 shRNA 克隆和 201 个源自萤火虫荧光素酶基因的 shRNA 进行了 RNAi 活性测量。对这两个数据集的结构-活性分析得出了一组 shRNA 功效的结构标准,将活性 shRNA 的频率相对于随机抽样提高了 5 倍。使用相同的文库选择靶向潜在致癌基因的 shRNA 来抑制乳腺癌细胞生长。所选 shRNA 靶向的基因富集了 10 条途径,其中 9 条途径先前与各种癌症、细胞周期进展或细胞凋亡有关。通过这种选择富集的 119 个基因,每个基因代表 2 到 6 个 shRNA,被鉴定为潜在的癌症药物靶点。针对该组中 22 个测试基因中的 19 个基因的短干扰 RNA 抑制了细胞生长,验证了这种用于高通量靶基因鉴定的策略的效率。